| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001697013-22-000003 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Eversept Partners, LP | 1697013 | EXELIXIS INC | COM | 30161Q104 | 4606 | 203156 | SH | SOLE | 203156 | 0 | 0 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001654954-22-006859 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Camber Capital Management LP | 1444043 | EXELIXIS INC | COM | 30161Q104 | 6801 | 300000 | SH | SOLE | 300000 | 0 | 0 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001630888-22-000001 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SG3 Management, LLC | 1630888 | EXELIXIS INC | COM | 30161Q104 | 793 | 35000 | SH | Put | SOLE | 35000 | 0 | 0 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001630888-22-000001 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SG3 Management, LLC | 1630888 | EXELIXIS INC | COM | 30161Q104 | 793 | 35000 | SH | Call | SOLE | 35000 | 0 | 0 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001606587-22-001192 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | J.W. COLE ADVISORS, INC. | 1404763 | EXELIXIS INC | COM | 30161Q104 | 5 | 110176 | SH | SOLE | NONE | 0 | 0 | 110176 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001587281-22-000002 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Virtus ETF Advisers LLC | 1587281 | EXELIXIS INC | COM | 30161Q104 | 496 | 21880 | SH | OTR | 0 | 21880 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001580642-22-002777 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Creative Planning | 1540235 | EXELIXIS INC | COM | 30161Q104 | 1727 | 76179 | SH | SOLE | 95 | 0 | 76084 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001567619-22-010956 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Point72 Hong Kong Ltd | 1599822 | EXELIXIS INC | COM | 30161Q104 | 95 | 4203 | SH | DFND | 1 | 0 | 4203 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001567619-22-010951 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Cubist Systematic Strategies, LLC | 1603465 | EXELIXIS INC | COM | 30161Q104 | 7454 | 328793 | SH | DFND | 1 | 0 | 328793 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:exel | nasdaq:exel Shareholders | 13F-HR | 0001567619-22-010947 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Point72 Asset Management, L.P. | 1603466 | EXELIXIS INC | COM | 30161Q104 | 9295 | 410000 | SH | Call | DFND | 0 | 0 | 410000 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Exelixis | Health Care | Pharmaceuticals & Biotechnology |